Repligen(RGEN) - 2025 Q3 - Quarterly Results

Exhibit 99.1 Repligen Corporation 41 Seyon Street Building #1, Suite 100 Waltham, Massachusetts 02453 Repligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance WALTHAM, Mass., October 28, 2025 -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for its third quarter of 2025, covering the three- and nine- month periods ended September 30, 2025. Provided in this press release a ...